Opportunities lie in developing efficient CAPA systems for pharma and medical device industries, enhancing root cause analysis, implementing effective solutions, and ensuring consistent product ...
Here are three important regulatory changes affecting parenteral packaging that pharmaceutical companies need to be aware of ...
Lipid-based nanoparticles are pivotal in modern medicine, improving drug delivery and mRNA therapies through innovative ...
Because scope 3 covers the entire value chain, pharma scientists should integrate sustainability into R&D, manufacturing, and ...
Developers of biosimilars will no longer be required by the FDA to conduct clinical trials to prove effectiveness.
President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...
The global Pharmaceutical Mini Batch Blender Market is poised for a decade of robust expansion as pharmaceutical companies ...
But last week, those words took on the force of law. On Tuesday, Texas Attorney General Ken Paxton filed a lawsuit against ...
Researchers at the Indian Institute of Science (IISc) have developed a highly efficient cell-free enzyme system that converts ...
AI and accelerated computing are transforming the bio/pharmaceutical sector by addressing organizational, technological, and ...
IM1240, the first CAPTN-3 tri-specific antibody targeting the novel tumor-associated antigen 5T4, advances toward first-in-human clinical trials, with an Investigational New Drug (IND) submission ...
Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback